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Abstract
Background: Supraglottic airway devices (SGA) are commonly used in pediatric anesthesia and serve as primary or
back-up devices for difficult airway management. Most SGA are marketed without proper clinical evaluation. The
purpose of this study was to evaluate the performance of the pediatric LMA Supreme™, Air-Q® and Ambu® Aura-i™.
Methods: This prospective observational study was performed at Bern University Hospital, Switzerland. With ethics
committee approval and a waiver for written informed consent 240 children undergoing elective surgery with an
ASA class I-III and a weight of 5-30 kg were included. Three different pediatric supraglottic airway devices were
assessed: The LMA Supreme™, Air-Q® and Ambu® Aura-i™. Primary outcome parameter was airway leak pressure.
Secondary outcome parameters included first attempt and overall success rate, insertion time, fiberoptic view
through the SGA, and adverse events. The primary hypothesis was that the mean airway leak pressure of each
tested SGA was 20 cmH2O ± 10%.
Results: None of the SGA showed a mean airway leak pressure of 20 cmH2O ± 10%, but mean airway leak
pressures differed significantly between devices [LMA Supreme™ 18.0 (3.4) cmH2O, Air-Q® 15.9 (3.2) cmH2O,
Ambu® Aura-i™ 17.3 (3.7) cmH2O, p < 0.001]. First attempt success rates (LMA Supreme™ 100%, Air-Q® 90%,
Ambu® Aura-i™ 91%, p = 0.02) and overall success rates (LMA Supreme™ 100%, Air-Q® 91%, Ambu® Aura-i™ 95%,
p = 0.02) also differed significantly. Insertion times ranged from 20 (7) seconds (Air-Q®) to 24 (6) seconds (LMA
Supreme™, <p = 0.005). Insertion was rated easiest with the LMA Supreme™ (very easy in 97% vs. Air-Q® 70%,
Ambu® Aura-i™ 72%, p < 0.001). Fiberoptic view was similar between the SGA. Adverse events were rare.
Conclusions: Airway leak pressures ranged from 16 to 18 cmH2O, enabling positive pressure ventilation with
all successful SGA. The highest success rates were achieved by the LMA Supreme™, which was also rated easiest
to insert.
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Background
Pediatric supraglottic airway devices (SGA) are being used
with great success and over 50% of general anesthetic pro-
cedures are managed with SGA [1]. A review article
showed that compared to tracheal intubation, the use of
SGA results in a decreased number of postoperative air-
way complications like desaturation, laryngospasm,
coughing or breath holding [2]. Also, a reduction in post-
operative nausea and vomiting [3, 4] and faster recovery
[4] has been reported. More advanced second generation
pediatric SGA have been released, but often without
evaluation in comparative, industry-independent studies
prior to marketing. This is reflected by a survey of the As-
sociation of Paediatric Anaesthetists of Great Britain and
Ireland in which 77% stated that trials assessing pediatric
SGA were necessary [1]. Interestingly, 88% preferred first
generation pediatric SGA over second generation SGA
[1]. Clinical trials on pediatric SGA are scarce [5–7]. Many
devices have been tested in adults [8, 9], but those results
cannot be extrapolated to children.
This prospective observational study evaluates the per-
formance of three pediatric SGA in 240 children: The
pediatric LMA Supreme™ (LMA-S™, LMA Company,
LeRocher, Victoria, Mahe, Seychelles), AirQ® (Cookgas®
LLC, St. Louis, USA) and Ambu® Aura-i™ (Aura-i™,
Ambu A/S, Ballerup, Denmark). Based on our previous
study [10] and published literature [5], pediatric SGA
are expected to provide airway leak pressures of about
20cmH2O. Our primary hypothesis was that the mean
airway leak pressure of each tested SGA was 20
cmH2O ± 10%.
Methods
This prospective observational study evaluated the clin-
ical performance of three pediatric SGA. It was per-
formed at the Department of Anaesthesiology and Pain
Therapy at the Inselspital, Bern University Hospital,
Switzerland. Ethical approval was given by the Internal
Review Board of the Bern University Hospital. The in-
ternal review board issued a waiver of written informed
consent. The study was registered through the inter-
national trials registry ClinicalTrials.gov under the iden-
tifier NCT01625858.
Participants, inclusion and exclusion criteria
Data of 240 patients were prospectively obtained. Patients
were boys and girls, 0–17 years old, weighing 5-30 kg,
with an ASA physical status I-III, and scheduled for elect-
ive surgery under general anesthesia with an SGA and a
planned operation time < 4 h. Exclusion criteria were risk
of aspiration, body mass index >35 kg m−2, cervical spine
disease, congenital anatomical malformation, known diffi-
cult airway, upper respiratory tract symptoms within
10 days, preoperative sore throat or poor dentition.
Devices
Three pediatric SGA were compared: The LMA-S™ and
the two intubation SGA Air-Q® and Aura-i™ (Fig. 1).
The LMA-S™ comes with a gastric channel, allowing for
a functional separation of the digestive and respiratory
tract. The AirQ® and the Aura-i™ do not feature a gas-
tric channel, but are SGA designed for management of
difficult airways and for intubation via the SGA. The
SGA were used according to manufacturer’s recom-
mendations and the size was determined by patients’
weight. To avoid selection bias, the specific SGA inves-
tigated was not chosen by the anesthesiologist in
charge, but, depending on availability on stock, by a
study nurse who was not involved in the anesthetic
management of the child.
Anesthesia
Anesthesia followed the standard operating procedures
of the Children’s Hospital Bern and was standardized to
guarantee equal depth of anesthesia. After premedication
and preoxygenation, anesthesia was induced by inhal-
ation of nitrous oxide and sevoflurane with final end-
tidal sevoflurane concentrations of 6%, or intravenously
with propofol (4 mg kg−1) and fentanyl (1–3 μg kg−1)
and/or alfentanil (20 μg kg−1). Adequate depth of
anesthesia was verified by loss of eyelash reflex, symmet-
ric small pupils, and lack of physical reaction to jaw-
thrust [10]. Bag mask ventilation was provided and the
SGA was lubricated with water-based K-Y Lubricating
Jelly (Johnson & Johnson Medical Limited, Gargrave,
Skipton, United Kingdom). An assistant performed the
jaw-thrust manoeuvre. The SGA was then inserted by an
attending, a resident or by a certified anesthesia nurse,
supervised by one of the senior pediatric anesthesiolo-
gists. A maximum of three insertion attempts was per-
formed and cuff pressure was set to 60 cmH2O using a
manometer (VBM GmbH, Sulz, Germany or Rüsch
GmbH, Kernen, Germany). SGA were secured with an
adhesive tape around the SGA spanning both cheeks. All
Fig. 1 The three different supraglottic airway devices evaluated
in this study. From left to right: Size 2 of the LMA-S™, Air-Q® and
the Aura-i™
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patients were ventilated using pressure controlled ventila-
tion. Following clinical standards, the SGA were usually
removed in a deeply sedated, spontaneously breathing
patient. The time of removal ultimately depended on the
decision of the anesthesiologist.
Measurements
All data were recorded by a member of the research
team who was not involved in clinical care. Recorded
demographic and anesthesia-related data included sex,
age, weight, height, ASA class, type of anesthesia induc-
tion, and duration of anesthesia.
Primary outcome was defined as mean airway leak
pressure [cmH2O] after placement of the SGA [10–12]:
Cuff pressure was set to 60cmH2O. Gas flow was 3 l
min−1 and the expiratory valve was closed at 30cmH2O.
The airway pressure at which a steady state was reached
was determined.
Secondary outcome parameters were first attempt
and overall success rate. Failures and reasons for device
failure were noted. Insertion time was measured from
face mask removal to successful ventilation of the lungs
[13, 14]. Subjective difficulty of handling was evaluated
by the anesthesiologist on a scale from 1 to 5 (1: very
easy, 2: easy, 3: difficult, 4: very difficult, 5: impossible),
as done before [8, 15, 16]. Feasibility of gastric catheter
insertion was noted.
When deemed clinically desirable by the attending
anesthesiologist, a fiberscope was inserted through the
airway port and in these cases, fiberoptic view was
graded as full view of the glottis (1), partial view of the
glottis (2), only epiglottic structures seen (3), or no
glottic/epiglottic structures visible (4), as done before
[17–19]. Epiglottic downfolding was noted.
Airway interventions after initial successful ventilation
were noted as well as adverse events like aspiration, re-
gurgitation, bronchospasm, obstruction, dental, tongue
or lip trauma, and blood on the removed SGA. The day
after surgery patients and/or parents were interviewed
about side effects like sore throat, hoarseness, dysphagia,
tongue numbness, and postoperative nausea and vomit-
ing (all graded as no/mild/moderate/severe).
Statistical analysis
Based on earlier studies, we expected leak pressures for
pediatric second generation supraglottic airway devices
to be around 20cmH2O [5, 10]. Our primary hypothesis
was that the mean airway leak pressure of each tested
SGA was 20 cmH2O ± 10%. More precisely this means
that the 95% confidence interval (CI) for mean airway
leak pressure of each tested SGA is within 20
cmH2O ± 10% (18–22 cmH2O). Given these expecta-
tions, a sample size calculation with a two-sided alpha
level of 0.05 and a power of 0.9 calculated 63 patients
per cohort necessary. To compensate for drop outs
or missing data, we planned to include 80 patients
per cohort.
Binary data were analysed by Chi square or by Fisher’s
exact test if more than 20% of expected values were
below 5. Ordinal data were evaluated using Kruskal-
Wallis test. Normal distribution for continuous data was
tested using Q-Q plots and Shapiro-Wilk W test. Inde-
pendent samples Kruskal-Wallis test was used for ana-
lysis of non-parametric data and ANOVA for analysis of
parametric data. For multiple comparisons of statistically
significant data, Student’s t-test was used for parametric
data and Mann–Whitney u-test for non-parametric data.
Bonferroni correction was applied. We performed a sub-
group analysis with subgroups according to children’s
weight (subgroup 1: 5–9.9 kg; subgroup 2: 10–19.9 kg;
subgroup 3: 20-30 kg).
Data are presented as numbers (%) for binary and or-
dinal data, as mean (SD) for parametric data, or as me-
dian (IQR) for nonparametric data. A probability of
p < 0.05 was considered statistically significant. Data
were analysed using Stata V.13.1 (StataCorp, College Sta-
tion, TX, USA).
Results
Data of 240 SGA insertions were evaluated. 201 children
(84%) were male and 39 (16%) female. Distribution of
gender and other demographic data did not differ be-
tween groups (p > 0.05, Table 1). Age ranged from 0.5 to
12.9 years. Weight ranged from 5.6 to 30.0 kg.
Primary outcome
For none of the SGA did the 95% confidence interval of
airway leak pressure range between 18 and 22 cmH2O,
leading to rejection of the hypothesis for all three SGA.
Mean airway leak pressures differed significantly be-
tween groups (p < 0.001) and were 18.0 (3.4) cmH2O
with the LMA-S™, 15.9 (3.2) cmH2O with the Air-Q® and
17.3 (3.7) cmH2O with the Aura-i™ (Table 2). In the
posthoc analysis, leak pressure with the Air-Q® was sig-
nificantly lower than with the LMA-S™ or the Aura-i™.
Secondary outcomes
First attempt and overall success rates differed signifi-
cantly between groups (p = 0.02, Table 2). The LMA-S™
achieved a 100% first attempt success rate. This was
statistically significantly better than the first attempt
success rate of the Air-Q® or the Aura-i™. The overall
success rate of the LMA-S™ was also statistically signifi-
cantly better than that of the Air-Q®. For the LMA-S™,
the 95% confidence interval of first attempt success rate
was above 90% (Table 2).
Reasons for device failures were massive air leaks (7
Air-Q®; 4 Aura-i™), but no problems with insertion of
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the SGA. There was no difference in the number of in-
sertion attempts (p = 0.28, Table 2).
Insertion time differed significantly between groups
(p = 0.005, Table 2). The Air-Q® was fastest to insert
and this was statistically significantly different to the
LMA-S™.
Ease of insertion was best with the LMA-S™ (Table 2)
and this was statistically significantly different to the
other two SGA.
Gastric catheterisation was possible in 99% of LMA-S™
cases. Due to the lack of a gastric tube this was not pos-
sible with the Air-Q® or the Aura-i™. Fiberoptic view was
Table 1 Patient characteristics and data regarding anesthesia
LMA-S™ Air-Q® Aura-i™ p-value
n = 80 n = 80 n = 80
Male sex - number (%)a 64 (80) 66 (83) 71 (89) 0.30
Age – years, median (IQR)b 5.0
(3.0–7.8)
5.0
(2.4–6.6)
5.0
(2.6–6.6)
0.47
Weight – kg, median (IQR)b 19.2
(15.0–25.8)
19.3
(13.0–24.0)
19.0
(13.3–23.0)
0.57
Height – cm, median (IQR)b 115
(97–127)
115
(90–123)
112
(97–120)
0.38
ASA I/II/III, number (%)c 55/24/1
(69/30/1)
63/16/1
(79/20/1)
60/19/1
(75/24/1)
0.64
Induction: inhalational/intravenous, number (%)a 39/41
(49/51)
30/50
(38/63)
29/51
(36/64)
0.21
Duration of anesthesia – min, median (IQR)b 100
(80–126)
87
(73–114)
93
(77–121)
0.09
atest statistics: Chi square test;
btest statistics: Kruskal Wallis test;
ctest statistics: Fisher’s exact test
Table 2 Supraglottic airway device performance. Bonferroni correction was applied for multiple comparisons
LMA-S™ Air-Q® Aura-i™ p-value
n = 80 n = 80 n = 80
First attempt success:
number (%); [95% CI]a
80 (100);
[95 to 100]b
72 (90);
[79 to 95]
73 (91);
[81 to 96]
0.02
Overall success:
number (%); [95% CI]c
80 (100);
[95 to 100]d
73 (91);
[81 to 96]
76 (95);
[87 to 99]
0.02
n = 80 n = 73 n = 76
Leak pressure - cmH2O: mean (SD); [95% CI]
e 18.0 (3.4);
[17.2 to 18.7]
15.9 (3.2);
[15.1 to 16.6]f
17.3 (3.7);
[16.4 to 18.1]
<0.001
Number of attempts
1/2/3: number (%)c
80/0/0
(100/0/0)
72/1/0
(99/1/0)
73/2/1
(96/3/1)
0.28
Ease of insertion:
number (%)g
77/2/0/0
(97/3/0/0)b
51/21/1/0
(70/29/1/0)
54/15/6/0
(72/20/8/0)
<0.001
Insertion time - seconds:
mean (SD); [95% CI]e
24 (6);
[23–25]d
20 (7);
[19–22]
22 (7);
[20–24]
0.005
n = 68 n = 45 n = 51
Fiberoptic view:
number (%)h
27/29/10/2
(40/43/15/3)
26/14/4/1
(58/31/9/2)
22/24/5/0
(43/47/10/0)
0.41
Epiglottic downfolding:
number (%)i
11 (17) 5 (11) 5 (10) 0.51
atest statistics: Chi square test;
bstatistically different to Air-Q® and Aura-i™;
ctest statistics: Fisher exact test;
dstatistically different to Air-Q®;
etest statistics: ANOVA;
fstatistically different to LMA-S™ and Aura-i™;
ggraded as very easy/easy/difficult/very difficult; data missing for 1 LMA-S™ and 1 Aura-i™; test statistics Fisher exact test;
hfiberoptic view graded as 1: full view of the glottis, 2: partial view of the glottis, 3: only epiglottic structures seen, 4: no glottic/epiglottic structures visible [17],
test statistics: Fisher exact test;
itest statistics: Chi square test, data missing for 2 LMA-S™ and 1 Air-Q®
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similar with all three SGA (p = 0.41, Table 2). A full view
of the glottis was achieved in 40% to 58%, and epiglottic
downfolding was rare (10–17%, Table 2).
Several SGA leaked air or dislodged after initially suc-
cessful ventilation, during lateral positioning for a caudal
block (0 LMA-S™, 2 Air-Q®, 2 Aura-i™, p = 0.40) or intra-
operatively (3 LMA-S™, 4 Air-Q®, 2 Aura-i™, p = 0.70).
Of the leaks occurring intraoperatively, all leaks with the
Air-Q® could be corrected by minor airway interventions
like pushing or taping down intraoperatively, while all
leaks with the LMA-S™ and the Aura-i™ led to removal
of the SGA.
Adverse events and side effects
Two children regurgitated at emergence from anesthesia
(Air-Q®). One child developed a laryngospasm requiring
intubation and tracheal suctioning revealed some
brownish secretion (Aura-i™). In all three cases, the post-
operative course was absolutely uneventful with normal
auscultation, continuous SpO2 > 95% at room air, and
timely discharge. Several children (1 LMA-S™, 1 Air-Q®,
1 Aura-i™) developed a short period of slight obstruction
during or after surgery. Laryngospasm developed with
one Air-Q® and one Aura-i™ during surgery and with
one LMA-S™ and two Aura-i™ after surgery. One child
with an Aura-i™ with bronchospasm was intubated. All
other spasms resolved spontaneously or by deepening
the anesthesia. One child with an Air-Q® showed minor
mucosal trauma. Blood stains were observed in 2 LMA-
S™, 1 Air-Q® and 5 Aura-i™.
There was no difference in sore throat (3–4%,
p = 0.76), hoarseness (3–9%, p = 0.37), numbness of the
tongue (0–1%, p = 1.00), nausea (9–22%, p = 0.051), or
vomiting (7–15%, p = 0.23) between groups. The only
difference between groups was dysphagia (p = 0.01),
resulting from a higher rate of dysphagia with the
LMA-S™ (6%) versus the other groups (0%). This missed
statistical significance in the posthoc comparison with
Bonferroni correction.
Subgroup analysis
Subgroup analysis was performed for subgroups accord-
ing to weight (Table 3), as done previously [10]. Since
numbers in subgroup 1 (5–9.9 kg) were low statistical
analysis was performed for subgroups 2 and 3 only.
Fiberoptic view significantly differed between subgroups
for the LMA-S™ and for the Aura-i™, with better views in
children weighing 20-30 kg compared to children weigh-
ing 10–19.9 kg. Insertion times differed for the Aura-i™
with faster insertion in children weighing 10–19.9 kg
compared to children weighing 20-30 kg (Table 3).
Comparison of the three SGA showed statistically sig-
nificant differences in insertion time within subgroups 2
and 3, and for leak pressure within subgroup 3 (Table 3).
Discussion
Confidence intervals of mean airway leak pressure were
below the range of 18–22 cmH2O with all three SGA.
Leak pressures ranged from 16 to 18 cmH2O and dif-
fered between devices. The Air-Q® showed the lowest
leak pressures, which were similar to previous studies
[6, 7, 20]. A previous study on the Ambu® Aura-i™ re-
ported mean airway leak pressures of 16 cmH2O [7], while
this was 18 cmH2O in our study. Leak pressure of the
LMA Supreme™ was similar to a previous study reporting
leak pressures of 20 cmH2O [5]. Overall, leak pressures
were lower than stated in our hypothesis, but still enabled
positive pressure ventilation with all successful SGA and it
is questionable whether the detected differences in leak
pressure are of clinical relevance. Of note, our hypothesis
was not based on a level of leak pressure that is associated
with successful positive pressure ventilation of children,
but on earlier results from other SGA [5, 10]. Taking the
different studies into account, it seems that the range of
measured leak pressures with different SGA is wide and
starts at 16cmH2O. Leak pressures of SGA in children are
therefore lower than those in adults [8, 21], but the clinic-
ally relevant point is that even with these low leak pres-
sures positive pressure ventilation of children is possible.
We previously published a prospective study on the
performance of the pediatric i-gel® and AuraOnce™ [10].
In that study the leak pressure of the i-gel was 22 (5)
and leak pressure of the AuraOnce™ was 19 (3) cmH2O.
The study used the same methods regarding anesthesia
and procedures as the current study, but included chil-
dren weighing 5-50 kg. Other studies of the i-gel®
showed similar leak pressures [22, 23]. Interestingly, leak
pressure therefore seems to be highest with the i-gel®,
which does not feature an inflatable cuff.
First attempt success rates in our study were lower
than in other publications, which showed rates of 100%
for the Aura-i™ [7] and the Air-Q® [6, 7], and 96–97% for
the LMA-S™ [5, 23]. Since SGA performance depends on
children’s age and weight [10], these results might be ex-
plained by differences in demographics. In our previous
study, first attempt success rates were 89% with the i-
gel® and 90% with the Ambu® AuraOnce™, similar to data
from the Air-Q® (90%) and Ambu® Aura-i™ (91%) in the
present study. Thus, the LMA-S™ with its 100% first at-
tempt success rate performed particularly well. Similarly,
the ease of insertion, as graded by the person inserting
the SGA on a commonly used subjective scale [9, 17, 18],
was best with the LMA-S™.
We previously defined a first attempt success rate with
a 95% confidence interval above 90% as the minimal
desirable target for airway management devices [24]. To
our knowledge, no other definition of a minimal thresh-
old for airway management devices exists. Several stud-
ies have shown success rates of ≥95% [5–7, 25], and we
Kleine-Brueggeney et al. BMC Anesthesiology  (2017) 17:119 Page 5 of 8
therefore postulated that a 95% confidence interval
above 90% should be a realistic, achievable goal for air-
way management devices. In the present study, only the
LMA-S™ achieved this target (95% CI of first attempt
success rate 95–100%).
Fiberoptic view was similar between the three SGA in
the present study, but a full view of the vocal cords was
achieved in only 40–58%. In contrast, our previous study
showed much better fiberoptic views with the i-gel® and
the AuraOnce™ (full view in 88 and 89%, respectively)
[10]. The full view of the glottic opening from the orifice
of the SGA is likely to reflect alignment of the SGA and
the larynx and could play an important role for intubation
through SGA. Interestingly, the Air-Q® and Aura-i™, but
not the i-gel® and AuraOnce™, are specifically marketed
for intubation. Success rates of 95–100% have been de-
scribed for fiberoptically guided intubation through the
Air-Q® [7, 26]. However, we showed that without fiber-
optic guidance, intubation success rates through the
pediatric Air-Q® and Aura-i™ are low, which is in line
with the results of the fiberoptic assessment [27].
Air-Q® insertion was fastest in the present study. How-
ever, the faster insertion will most likely be of minimal
clinical relevance.
In three children, anesthesia personnel reported regurgi-
tation or possible aspiration. Clinical evaluation of minor
aspiration remains difficult and it is unclear whether these
children aspirated or not. In any case, their clinical course
was completely uneventful. Temporary airway obstruction
occurred in several children and rates were similar to
Table 3 Subgroup analysis according to body weight for each device. Since numbers in subgroup 1 are low statistical analysis was
performed comparing subgroup 2 and 3 only
Group 1 Group 2 Group 3 p-value
(5–9.9 kg) (10–19.9 kg) (20–30 kg)
LMA-S™ Number of patients 1 39 40
First attempt success, n (%)a 1 (100) 39 (100) 40 (100) 1.00
Overall success, n (%)a 1 (100) 39 (100) 40 (100) 1.00
Leak pressure - cmH2O, median (IQR)
b 16 18 (16–19) 18 (16–20) 0.73
Insertion time - seconds, median (IQR)b 21 24 (21–28) 22 (19–27) 0.13
Fiberoptic view, n (%)c 0/0/1/0
(0/0/100/0)
9/15/7/2
(27/45/21/6)
18/14/2/0
(53/41/6/0)
0.048
Air-Q® Number of patients 5 36 39
First attempt success, n (%)a 5 (100) 33 (92) 34 (87) 0.71
Overall success, n (%)a 5 (100) 33 (92) 35 (90) 1.00
Leak pressure - cmH2O, median (IQR)
b 20 (17–22) 16 (15–18) 15 (12–17) 0.16
Insertion time - seconds, median (IQR)b 17 (14–22) 21 (17–24) 20 (15–24) 0.61
Fiberoptic view, n (%)c 2/1/1/0
(50/25/25/0)
10/9/0/1
(50/45/0/5)
14/4/3/0
(67/19/14/0)
0.054
Aura-i™ Number of patients 2 41 37
First attempt success, n (%)a 2 (100) 38 (93) 33 (89) 0.70
Overall success, n (%)a 2 (100) 40 (98) 34 (92) 0.34
Leak pressure - cmH2O, median (IQR)
b 13; 20 18 (15–19) 18 (15–20) 0.17
Insertion time - seconds, median (IQR)b 10; 28 19 (15–23) 25 (20–30) <0.001
Fiberoptic view, n (%)c 1/0/0/0
(100/0/0/0)
5/17/5/0
(19/63/19/0)
16/7/0/0
(70/30/0/0)
<0.001
p-values comparing the 3 SGA First attempt success d NA 0.21 0.05
Overall success d NA 0.11 0.10
Fiberoptic viewd NA 0.06 0.19
Leak pressuree NA 0.06 <0.001
Insertion timee NA <0.001 0.007
atest statistics Fisher exact test;
bfor variables with n ≤ 3 original data are given instead of median with IQR; test statistics: Mann Whitney U test;
cfiberoptic view graded as 1: full view of the glottis, 2: partial view of the glottis, 3: only epiglottic structures seen, 4: no glottic/epiglottic structures visible; 17 test
statistics Fisher exact test
dwithin subgroup comparison, test statistics Fisher exact test;
ewithin subgroup comparison, test statistics Kruskal Wallis test
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reported rates [25]. Most airway obstructions occurred to-
wards the end of anesthesia. Due to the observational
character of the study, the time of removal of the SGA
varied and it is unclear how the depth of anesthesia influ-
enced the occurrence of airway obstructions. Other ad-
verse events like trauma or side effects such as sore throat
were minor and rare.
More boys than girls were included in this study. This
was due to a high percentage of circumcisions and likely
does not influence outcomes. The ratio of boys and girls
did not differ between groups.
The study was not randomized but observational, car-
rying the risk of selection bias. To prevent that anesthe-
siologists could choose a device of their liking, a study
nurse who was not involved in anesthetic management
of the patient chose the device. Also, demographic data
were equally distributed between groups, showing that
selection bias is rather unlikely.
Finally, our study included few patients weighing less
than 10 kg (n = 8). SGA tend to perform differently in
smaller and larger children [7, 10] and our results have
to be interpreted with caution when transferred to youn-
ger patients. However, there was no statistical difference
in age between the different SGA groups.
Conclusions
Leak pressure was lowest with the Air-Q®, but with leak
pressures ranging from 16 to 18cmH2O, positive pressure
ventilation was possible with all successfully inserted SGA.
The LMA-S™ reached the highest first attempt and overall
success rates, and was particularly easy to insert.
Abbreviations
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